(1 - 21 from 22
)
Potential PAH Therapy, KER-012 Also Prevents Bone Loss in Rat ...pulmonaryhypertensionnews.com › › ker-012-prevents-bone-l...
pulmonaryhypertensionnews.com
Oct 6, · ... bone loss resulting from secondary osteoporosis, such as in PAH,” Jasbir Seehra, PhD, Keros' president and CEO, said in a press release.
Keros The…utics CEO Jasbir Seehra's pay jumps ExecPaywww.execpay.org › news › keros-the…utics-inc compensation-4496
Apr 19, · Jasbir Seehra, Chief Executive Officer, received $9.5M in total, which increased by 1,268% compared to % of Seehra's compensation, ...
Bio… company Keros The…utics sets price range for ...www.spglobal.com › news-insights › latest-news-headlines › biopharmaceu...
Apr 1, · The company — led by President and CEO Jasbir Seehra — has applied to list its shares on the exchange under the ticker symbol KROS.
Keros The…utics Venture Capital and Private Equity Financingswww.vcnewsdaily.com › venture-funding
Jan 8, · Headquartered in Lexington, Massachusetts, Keros The…utics is led by President and CEO Dr. Jasbir Seehra, who has over three decades of ...
sorted by relevance / date